Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Charlotte faith leaders hold interfaith forum on Black and Palestinian solidarity - 2Well known SUVs With Low Energy Utilization In 2024 vote
- 3Manual for Instructive Application for Youngsters
- 4CPA Canada appoints eight directors as new governance model takes effect
- 5A Timeline of Rising Antisemitism in Australia
- Turning into a Distributed Writer: My Composing Process
- The breakout star of NASA's Artemis 2 moon mission isn't an astronaut — it's the space toilet
- See as Your #1: These Low-Sugar Food sources You Ought to Attempt
- Why Tourists May Want To Reconsider Traveling To This Popular Spot In Italy In 2026
- Pick Your Favored kind of soup
- 7 Odd Apparatuses to Make Your Party Stick Out!
- Recalled Super Greens diet supplement powder sickens 45 with salmonella
- Top 20 Style Brands for Pioneers
- UN rights chief: Israel's new Gaza aid agency rules 'outrageous'
